Related Experiment Video
Updated: Jul 16, 2025

Detecting the Ligand-binding Domain Dimerization Activity of Estrogen Receptor Alpha Using the Mammalian Two-Hybrid Assay
Published on: December 19, 2018
AIB1/SRC-3/NCOA3 function in estrogen receptor alpha positive breast cancer
Amber J Kiliti1,2, Ghada M Sharif1, Mary Beth Martin1,2
1Department of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC, United States.
The steroid receptor coactivator AIB1 is an oncogene that drives breast cancer progression and endocrine therapy resistance. Targeting AIB1 offers a potential therapeutic strategy for breast cancer treatment.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Estrogen receptor alpha (ERα) is crucial for initiating and progressing most breast cancers.
- Steroid receptor coactivator AIB1 amplifies ERα-mediated gene transcription.
- AIB1 is an oncogene overexpressed in some breast cancers, contributing to tumor progression and therapy resistance.
Purpose of the Study:
- To review the normal and pathological functions of AIB1 in breast cancer.
- To examine AIB1's ERα-dependent and ERα-independent actions.
- To discuss AIB1's genomic conservation, protein evolution, and therapeutic targeting.
Main Methods:
- Literature review of AIB1's role in ERα signaling.
- Analysis of AIB1's oncogenic functions in breast cancer.
- Examination of AIB1's evolutionary and genomic aspects.
Main Results:
- AIB1 acts as an oncogene, promoting breast cancer via ERα-dependent and -independent pathways.
- Overexpression of AIB1 correlates with tumor progression and resistance to endocrine therapy.
- AIB1's conserved functions and evolutionary trajectory highlight its significance.
Conclusions:
- AIB1 is a key player in breast cancer pathogenesis and endocrine resistance.
- Targeting AIB1 presents a promising therapeutic avenue for breast cancer treatment.
- Understanding AIB1's multifaceted roles is essential for developing effective cancer therapies.
Related Concept Videos
Transducer Mechanism: Nuclear Receptors
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
The Nucleolus
Target Cell Response to Hormones
Notably, the cellular response can be regulated by altering the number of receptors expressed in the cell. For example, prolonged exposure to elevated hormone levels results in a gradual decline or down-regulation in the number of receptors for that specific hormone on the cell surface. Conversely, in response to low hormone levels, cells may use up-regulation, producing an...
Intracellular Hormone Receptors
Endocrine Signaling
Co-activators and Co-repressors

